Table 4.
Unadjusted Analysis OR (95% CI) | |
---|---|
Male gender | 0.62 (0.31–1.22) |
Age (years) | 1.00 (0.98–1.02) |
History of DM | 0.74 (0.37–1.47) |
History of cancer | 1.47 (0.62–3.44) |
XDR Strain | 1.5 (0.34–6.60) |
Bacteria | |
K. pneumoniae | Reference |
E. coli | 0.98 (0.46–2.11) |
Enterobacter species | 1.25 (0.44–3.52) |
Resistance type | |
ESBL | 0.67 (0.32–1.39) |
CPE | 2.35 (0.71–8.54) |
Other | Reference |
Ventilation | 0.30 (0.14–0.60) |
ESRD | 1.05 (0.35–3.92) |
Prior 90 days antibiotics use | 0.43 (0.18–0.99) |
Prior 4 weeks antibiotics use | 0.54 (0.25–1.15) |
Inotropes | 0.60 (0.29–1.16) |
ICU length stay ≥ 72hrs until culture | 1.19 (0.60–2.36) |
Appropriateness of therapy | 0.67 (0.33–1.33) |
Abbreviations: CI, confidence interval; CPE, carbapenem-producing Enterobacteriaceae; DM, diabetes mellitus; ESBL, extended-spectrum β-lactamase; ESRD, end-stage renal disease; ICU, intensive care unit; OR, odds ratio, SD, standard deviation; XDR, extensive drug-resistant.